Home/Filings/4/0001349929-15-000021
4//SEC Filing

CANCER GENETICS, INC 4

Accession 0001349929-15-000021

CIK 0001349929operating

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 4:44 PM ET

Size

5.3 KB

Accession

0001349929-15-000021

Insider Transaction Report

Form 4
Period: 2015-06-12
Transactions
  • Sale

    Common Stock, par value $0.0001 per share

    2015-06-12$12.01/sh7,000$84,052176,977 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were exercised in multiple transactions at prices ranging from $12.00 to $12.05, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares exercised at each separate price within the ranges set forth in footnote (2)to this Form 4.

Issuer

CANCER GENETICS, INC

CIK 0001349929

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001349929

Filing Metadata

Form type
4
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:44 PM ET
Size
5.3 KB